Older Singaporeans Support Healthier SG, but Lifestyle Habits Still Lag Behind
New SMU research reveals critical gaps in preventive health, lifestyle habits, and continuity of care as Singapore transitions into a super-aged society. Despite strong pro-health policies, everyday adoption - especially among older adults - remains limited. Bridging this gap requires environmental nudges that make healthy choices easier, more intuitive,...
Lynk Pharmaceuticals Announces Key Phase II Clinical Results of LNK01004 for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis
HANGZHOU, China and SHANGHAI and BOSTON, Nov. 19, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company, today announced key results from its Phase II clinical trial of LNK01004, a skin restricted, soft pan-JAK inhibitor, for the treatment of atopic dermatitis (AD). This randomized, double-blind, vehicle-controlled Phase II...
Rafa Laboratories Awarded up to $186 Million by BARDA to Develop a Life-Saving Intramuscular TXA Injection for Prehospital Care
JERUSALEM, Nov. 19, 2025 /PRNewswire/ -- Rafa Laboratories, a global leader in Chemical, Biological, Radiological, and Nuclear hazards medical countermeasures and Biodefense, today announced it has been awarded with a landmark development contract by the Biomedical Advanced Research and Development Authority (BARDA), part of Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services...
Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory Strategy
SYDNEY, Nov. 19, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized single-patient expanded access protocol combining paxalisib with pembrolizumab (Keytruda®) and standard chemotherapy has achieved an initial immune-complete response (iCR) per iRECIST criteria. This outcome suggests a profound...
Datasea Inc. Issues Statement Regarding Recent Market Activity
BEIJING, Nov. 18, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company") ,a Nevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today issues a brief statement regarding recent trading activity in its common stock. The Company has observed fluctuations in its share price and trading volume over the past several days. Datasea emphasizes...
Feelingirl FeelCare™ Collection Wins American Good Design Award for Merging Medical Precision with Everyday Elegance
LOS ANGELES, Nov. 18, 2025 /PRNewswire/ -- Feelingirl, a brand redefining shapewear through comfort and confidence, announced that its FeelCare™ Collection, designed specifically for women recovering from surgery, has been honored with the prestigious American Good Design Award for its seamless integration of medical precision and design aesthetics. The accolade, presented by the International Award Association, recognizes outstanding achievements...
Kangpu to Present Latest Study Results of epaldeudomide (KPG-818) at the 67th ASH Annual Meeting
HEFEI, China, Nov. 18, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals announced today that the company will deliver a poster presentation to highlight the Phase I clinical trial results of epaldeudomide (KPG-818) for the treatment of hematological malignancies at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in...
HKUST Receives Government’s Approval to Establish a New Medical School
Dedicated to Nurturing a New Generation of DoctorsSupporting Hong Kong Become a Hub for Medical Innovation HONG KONG, Nov. 18, 2025 /PRNewswire/ -- The establishment of Hong Kong's third medical school at The Hong Kong University of Science and Technology (HKUST) was approved today by the Hong Kong SAR Government (the Government). This landmark decision underscores the visionary leadership...
CRScube acquires Mednet to expand global eClinical capabilities
SEOUL, South Korea and MINNEAPOLIS, Nov. 18, 2025 /PRNewswire/ -- CRScube has announced the successful acquisition of Mednet, marking a key milestone in its global strategic growth and expansion into the North American market. The transaction unites two respected eClinical technology vendors with complementary strengths and a shared commitment to thoughtful innovation, collaboration,...
The 42nd Sandy Bay Charity Fair: Celebrating 70 Years of Transforming Lives by The Society for the Relief of Disabled Children (SRDC) and The Duchess of Kent Children’s Hospital
HONG KONG, Nov. 18, 2025 /PRNewswire/ -- The Society for the Relief of Disabled Children (SRDC), one of Hong Kong's longest-standing non-profit organisations, is proud to announce the 42nd Sandy Bay Charity Fair at The Duchess of Kent Children's Hospital (DKCH). The event has taken place on Saturday, 15th November 2025, from 10:00 am to 5:00 pm. ...
